65110-23-8 Usage
Uses
Used in Organic Synthesis:
(2E)-2-[4-(pentyloxy)benzylidene]hydrazinecarbothioamide is used as a reagent in the synthesis of other organic compounds, contributing to the creation of a diverse range of chemical products.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, (2E)-2-[4-(pentyloxy)benzylidene]hydrazinecarbothioamide is utilized for its potential applications, possibly due to its unique structural features that may interact with biological targets or pathways.
Used in Biological Research:
(2E)-2-[4-(pentyloxy)benzylidene]hydrazinecarbothioamide may possess biological activity, and it is subject to further research to understand its properties and potential uses in biological systems, which could include therapeutic applications or as a tool in biological studies.
Check Digit Verification of cas no
The CAS Registry Mumber 65110-23-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,5,1,1 and 0 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 65110-23:
(7*6)+(6*5)+(5*1)+(4*1)+(3*0)+(2*2)+(1*3)=88
88 % 10 = 8
So 65110-23-8 is a valid CAS Registry Number.
65110-23-8Relevant academic research and scientific papers
Rational design and synthesis of 4-O-substituted phenylmethylenethiosemicarbazones as novel tyrosinase inhibitors
Yi, Wei,Cao, Rihui,Chen, Zhiyong,Yu, Liang,Wen, Huan,Yan, Qin,Ma, Lin,Song, Huacan
experimental part, p. 752 - 754 (2010/07/15)
In continuing our program aimed to search for tyrosinase inhibitors, a series of novel 4-O-substituted phenylmethylenethiosemicarbazones were rational designed, synthesized and their inhibitory effects on the diphenolase activity of mushroom tyrosinase were also evaluated. A fair number of compounds were found to have significant tyrosinase inhibitiory activity. Particularly, the IC50 values of compounds 3a-g, 3j and 3s were of the same magnitude as tropolone, one of the best tyrosinase inhibitors known so far. Furthermore, the structure-activity relationships of these compounds were also investigated. All these data suggested that these molecules might be utilized for the development of new candidate for the treatment of dermatological disorders, and further development of such compounds may be of interest.
